These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16631003)

  • 1. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging.
    Thiele H; Kappl MJ; Conradi S; Niebauer J; Hambrecht R; Schuler G
    J Am Coll Cardiol; 2006 Apr; 47(8):1641-5. PubMed ID: 16631003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of infarct size changes with delayed contrast-enhanced magnetic resonance imaging and electrocardiogram QRS scoring during the 6 months after acutely reperfused myocardial infarction.
    Bang LE; Ripa RS; Grande P; Kastrup J; Clemmensen PM; Wagner GS
    J Electrocardiol; 2008; 41(6):609-13. PubMed ID: 18790502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial.
    Kim RJ; Albert TS; Wible JH; Elliott MD; Allen JC; Lee JC; Parker M; Napoli A; Judd RM;
    Circulation; 2008 Feb; 117(5):629-37. PubMed ID: 18212288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidetector computed tomography in reperfused acute myocardial infarction. Assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging.
    Jacquier A; Boussel L; Amabile N; Bartoli JM; Douek P; Moulin G; Paganelli F; Saeed M; Revel D; Croisille P
    Invest Radiol; 2008 Nov; 43(11):773-81. PubMed ID: 18923256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring.
    Engblom H; Wagner GS; Setser RM; Selvester RH; Billgren T; Kasper JM; Maynard C; Pahlm O; Arheden H; White RD
    Am Heart J; 2003 Aug; 146(2):359-66. PubMed ID: 12891208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of contrast agent-enhanced versus non-contrast agent-enhanced real-time three-dimensional echocardiography for analysis of left ventricular systolic function.
    Krenning BJ; Kirschbaum SW; Soliman OI; Nemes A; van Geuns RJ; Vletter WB; Veltman CE; Ten Cate FJ; Roelandt JR; Geleijnse ML
    Am J Cardiol; 2007 Nov; 100(9):1485-9. PubMed ID: 17950813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction.
    Abdel-Aty H; Zagrosek A; Schulz-Menger J; Taylor AJ; Messroghli D; Kumar A; Gross M; Dietz R; Friedrich MG
    Circulation; 2004 May; 109(20):2411-6. PubMed ID: 15123531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fast navigator-gated 3D sequence for delayed enhancement MRI of the myocardium: comparison with breathhold 2D imaging.
    Nguyen TD; Spincemaille P; Weinsaft JW; Ho BY; Cham MD; Prince MR; Wang Y
    J Magn Reson Imaging; 2008 Apr; 27(4):802-8. PubMed ID: 18302233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.
    Ganame J; Messalli G; Dymarkowski S; Rademakers FE; Desmet W; Van de Werf F; Bogaert J
    Eur Heart J; 2009 Jun; 30(12):1440-9. PubMed ID: 19346229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction.
    Roes SD; Kelle S; Kaandorp TA; Kokocinski T; Poldermans D; Lamb HJ; Boersma E; van der Wall EE; Fleck E; de Roos A; Nagel E; Bax JJ
    Am J Cardiol; 2007 Sep; 100(6):930-6. PubMed ID: 17826372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating global and regional left ventricular function in patients with reperfused acute myocardial infarction by 64-slice multidetector CT: a comparison to magnetic resonance imaging.
    Sarwar A; Shapiro MD; Nasir K; Nieman K; Nomura CH; Brady TJ; Cury RC
    J Cardiovasc Comput Tomogr; 2009; 3(3):170-7. PubMed ID: 19527893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the correlation of the Selvester QRS scoring system with cardiac contrast-enhanced magnetic resonance imaging-measured acute myocardial infarct size in patients with and without thrombolytic therapy.
    Rovers WC; van Boreen MC; Robinson M; Martin TN; Maynard C; Wagner GS; Gorgels AP
    J Electrocardiol; 2009; 42(2):139-44. PubMed ID: 19159901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
    Klumpp B; Fenchel M; Hoevelborn T; Helber U; Scheule A; Claussen C; Miller S
    Invest Radiol; 2006 Sep; 41(9):661-7. PubMed ID: 16896300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty.
    Tarantini G; Razzolini R; Cacciavillani L; Bilato C; Sarais C; Corbetti F; Marra MP; Napodano M; Ramondo A; Iliceto S
    Am J Cardiol; 2006 Oct; 98(8):1033-40. PubMed ID: 17027566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New generation 3-dimensional echocardiography for left ventricular volumetric and functional measurements: comparison with cardiac magnetic resonance.
    Nikitin NP; Constantin C; Loh PH; Ghosh J; Lukaschuk EI; Bennett A; Hurren S; Alamgir F; Clark AL; Cleland JG
    Eur J Echocardiogr; 2006 Oct; 7(5):365-72. PubMed ID: 16916621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement.
    Wagner A; Mahrholdt H; Thomson L; Hager S; Meinhardt G; Rehwald W; Parker M; Shah D; Sechtem U; Kim RJ; Judd RM
    J Am Coll Cardiol; 2006 May; 47(10):2027-33. PubMed ID: 16697321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging.
    Thiele H; Kappl MJ; Linke A; Erbs S; Boudriot E; Lembcke A; Kivelitz D; Schuler G
    Eur Heart J; 2007 Jun; 28(12):1433-9. PubMed ID: 17556347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function.
    Steen H; Giannitsis E; Futterer S; Merten C; Juenger C; Katus HA
    J Am Coll Cardiol; 2006 Dec; 48(11):2192-4. PubMed ID: 17161244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed-enhancement magnetic resonance imaging at 3.0T using 0.15mmol/kg of contrast agent for the assessment of chronic myocardial infarction.
    Yang J; Ma H; Liu J; Wang C; Shi Y; Xie H; Huo F; Liu F; Lin K
    Eur J Radiol; 2014 May; 83(5):778-82. PubMed ID: 24565750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.